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COATING OF POLYURETHANE URETERAL STENTS WITH 
POLY(VINYL PYRROLIDONE) BY PLASMA AND CHEMICAL METHODS 
 
SUMMARY 
 
The further evolution of human health care brings the need of  biocompatible 
devices. Amoung the searches, there has been fascinating trend to use biocompatible 
polymeric materials in biomedical field. Because the polymers can be synthesized 
with a wide range and they can be modified according to achieve various properties, 
a large number of polymeric materials are used as medical devices today. 
The composition, properties and forms of the polymers can be adjusted easily and 
with these in mind, the polymers are easily achieved in the form of gels, films, fibers 
or solids. Polymers are used in wide varioty of medical field such as, bone plates, 
ligaments, heart valves, ureteral stents, contact lenses, othopedic implants and etc. 
In urinary systhem tubes, valves or canalsmight be obstructed and thisobstrucrtions 
might be the reason of stones, tumors and etc. Ureteral stents are used to unblock the 
obstructed area in the urinary system. These obstructions causes ureter system to be 
disfunctioned and un-usefull for the body. These days the devices that are being used 
in urinary system are mostly synthetic polymeric materials. The reason for that 
phenomena is that the usega of glass, tantalum or vitallium failed and caused de-
obstruction yet polymeric materials gave more positive results then those materials. 
For a polymeric material to be used as ureteral stent it has to have certain type of 
properties such as biocompatibility, biological inertia, chemical stability in urine, 
resistance to encrustation and infection, excellent flow properties and non irritation.   
Polyurethanes have been widely used as biomedical materials due to their good 
mechanical and adjustable physical properties. Most importantly their synthesis are 
medically pure, and thus, they have perfect blood and tissue 
compatibility.Polyurethanes can be used as urethral stents, catheters and other 
urological implants. However, the permanent contact with urine causes encrustations 
on the surface of the polyurethane because of the crystals and deposits consisting of 
the ionic and organic compounds in urine. The encrustation on the inner or outer 
surface of polyurethane leads to a higher risk of infection and obstruction. In order to 
avoid these, the surface of polyurethane should be modified. Generally hydrophilic 
coating of the polyurethane surface is preferred tomake the surface lubricious and to 
reduce encrustation. There are several kinds of techniques to coat the surface. 
Surface modification by plasma is a clean and effective way to modify and to form 
reactive groups on the surface. After treating the polymer surface with plasma, dip-
coating into a hydrophilic polymer solution such as poly (vinyl pyrrolidone) (PVP), 
makes the surface lubricious and hydrophilic. Chemical treatment is also an effective 
way to modify the surface. After treating the polyurethane with chemicals dipping 
into PVP solution should also give a lubricious and hydrophilic surface. Other than 
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modifying the surface, blending with a hydrophilic polymer can be researched to 
compare the encrustation happening onto the surface of TPU. 
In this work, commercial thermoplastic polyurethane, Catbothane™ PC-3595A-B20 
which ispolycarbonate-based aliphatic thermoplastic polyurethane (TPU) was used 
as stent material. For the coating of the TPU surface, two kinds of techniques were 
used, plasma and chemical treatments. Plasma treatments have been performed in 
two steps. In the first step, clean and reactive surfaces have been achieved by 
exposing the TPU films in a certain force and time (50W, 10 min) with argon 
plasma. For second step, the activated TPU films were dipped in PVP solutions (5-
100%) for 15 minutes. The dipping process has been applied for two times. The 
second technique for coating the surface of the TPU is chemical treatment. This 
technique was performed in two steps also. Firstly the TPU films were dipped into a 
toluene solution containing 10% ethylene glycol dimethacrilate and 8% cumene 
hydro peroxide for 5 minutes. With the help of cumene hydro peroxide -that has an 
initiator specialty- reactive species occured on the surface of the TPU films. Then, 
the activated TPU films were dipped in PVP solutions (5-100%) for 15 minutes. This 
second step was also applied for two times. The effect of the PVP concentration on 
the coating performance has been investigated.Additionally, the blend of TPU and 
PVP has been prepared and its surface properties was determined. Both TPU and 
PVP were dissolved seperately in N,N-dimethyl acetamide and then they were mixed 
with each other with magnetic stirrer. After that, the solution was cast into a petri 
dish and the solvent has been evaporated. 
 After the coating and blend procedure, coated, uncoated and blendedTPU films were 
dipped in an artificial urine solution and placed on a shaker at 37 
o
C for two weeks.  
For characterization of all polymer films contact angle measurements, Fourier 
transform infrared spectorscopy (FT-IR), differencial scanning calorimmetry (DSC), 
thermal gravimmetric analysis (TGA) were used.  The effect of the artificial urine on 
the coated, uncoated and blended TPU films were examined with Atomic force 
microscope (AFM). 
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POLİÜRETAN URETER STENTLERİN YÜZEYİNİN PLAZMA VE 
KİMYASAL YÖNTEMLER KULLANILARAK POLİ(VİNİL PİRROLİDON) 
İLE KAPLANMASI 
 
ÖZET 
 
İnsan sağlığının korunmasının gelecekteki gelişimi biyo uyumlu malzemelere olan 
ihtiyacın artmasına neden olmaktadır. Bu amaçla yapılan çalışmaların ve 
araştrmaların sonuçlarına bakıldığında, biyomedikal alanda yapılan vücut içi 
uygulamalar için biyo uyumlu polimerlerin kullanılabilirliği göze çarpmakta ve son 
zamanlarda en çok kullanılan biyomedikal malzemelerin polimerik malzemelerden 
elde edildiği görülmektedir. Polimerler çok geniş bir çeşitlilik aralığında 
sentezlenebildikleri, amaca yönelik olarak morfolojik ve yüzeysel değişikliklere 
yatkın oldukları ve bir takım yöntemler uygulanarak bir çok farklı özelliğe sahip 
olabildikleri için biyomedikal alanda kullanımları son zamanlarda artmıştır. 
Polimerlerin kompozisyonlarının, özelliklerinin ve formlarının kolayca 
değiştirilebilir olması film, fiber, jel veya katı olarak elde edilmelerine olanak 
sağlamıştır. Polimerler yukarıda sayılan sebeplerden ötürü bir çok farklı medikal 
alanda aktif olarak kullanılmaktadır. Örneğin, kemik dolgu malzemesi, kalp 
kapakçığı, ureter stent, kontakt lens, ortopedik implant, bağ dokusu vb. gibi bir çok 
hasarlı yapı ve dokuyu  insan vücudunda işlev görür hale getirip, tamamlamak üzere 
kullanılmaktadırlar. 
Ureter sisteme ait kanallar, tüpler veya valfler taşlaşmalar veya tömürler gibi 
nedenlerden ötürü tıkanabilirler. Bu tıkanıklık üreter sistemin işlev görmesini 
engellemekte ve vücut için kullanışsız hale gelmesine sebep olmaktadır. Bu durumda 
devreye giren üreter stentler bu tıkanıklıkları gidermek amacıyla tüp veya kanallara 
nakledilmektedir. Ureter sistem için kullanılan biyomedikal implantlar genellikle 
polimerik malzemelerden üretilmektedir. Polimerik malzemelerin sıklıkla 
kullanılmasının sebebi olarak, daha önceden kullanılmış olan cam, tantal ve 
vitalliumun stentlerin işlevini görürken yeniden tıkanmaya sebep olması buna 
karşılık olarak polimerik malzemelerin daha olumlu sonuçlar vermesi gösterilebilir. 
Polimerik bir malzemenin ureter stent olarak kullanılabilmesi için belli başlı bazı 
özelliklere sahip olmaları gerekmektedir.  Bu özelliklerin arasında, biyouyumluluk, 
biyolojik inertlik, idrar içinde kimyasal stabilite, taşlaşma ve enfeksiyona 
dayanıklılık  ve tahrişe karşı dayanıklılık sayılabilir. Bu özelliklere sahip farklı 
polimerler bulunmaktadır.   
Poliüretanlar uygun mekanik özellikleri, ayarlanabilir fiziksel özellikleri, medikal 
saflıkta sentezlenebiliyor olmaları ve mükemmel kan ve doku uyumluluğuna sahip 
olmaları nedeniyle biyomedikal olarak yaygın bir şekilde kullanılmaktadırlar. Bu 
özelliklere sahip olduğu için poliüretanlar üreter sistemde stent, kateter ve diğer faklı 
implant çeşitleri olarak görev alabilmektedirler. Tüm bu istenilen özelliklere sahip 
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olmakla birlikte, sürekli idrarla temas halinde olan poliüretanların yüzeylerinde, 
idrarın yapısında bulunan kristal tuz ve tortuların sahip olduğu  iyon ve organik 
maddeler taşlaşmaya yol açarlar. Poliüretanların iç veya dış yüzeylerindeki 
taşlaşmalar çok daha riskli bir enfeksiyona ve yeniden tıkanmaya neden olur. Bu 
istenmeyen durumu gidermek için, poliüretan stentin yüzeyinin modifikasyonu 
sıklıkla uygulanan bir yöntemdir. Modifikasyon sürecinde uygulanılabilecek farklı 
yöntemler bulunmaktadır. Yüzey özelliklerini iyileştirmek adına yüzey 
modifikasyonu uygulaması ile yüzeyi taşlaşmaya daha az yatkın bir malzeme ile 
kaplama uygulaması, morfolojik özelliklerini değiştirip iyileştirmek için başka bir 
polimer ile karışımının hazırlanması gibi yöntemler ile poliüretanlar sahip olduğu 
mükemmel mekanik özellikleri koruyup aynı zamandada taşlaşmaya ve enfeksiyona 
karşı daha dayanıklı bir hale getirilebilirler. Yüzey modifikasyonu ile yüzey kaplama 
uygulaması için birkaç farklı yöntem bulunmaktadır. Poliüretan yüzeyi kimyasallar 
ile muamele edilip aşı (graft) yöntemi ile poliüretan yüzeyine farklı bir polimer 
kovalent bağlanabilir veya plazma modifikasyon yöntemi ile yüzeyde reaktif grupları 
oluşturulup kimyasal kaplama sağlanılabilir. Plazma modifikasyon yöntemi yüzeyi 
modifiye etmek ve reaktif gruplar oluşturmak için etkili ve temiz bir yöntemdir. 
Kimyasal muamele de  yüzey modifikasyonu için etkin bir yöntemdir.  
Poliüretan yüzeyin modifiye edileceği, kaplamanın yapılacağı malzeme son derece 
önemlidir. Bu malzeme taşlaşmayı en aza indirgeyen ve enfeksiyona karşı dayanıklı 
bir malzeme olmalıdır. Poliüretan yüzeyinin hidrofilik bir madde ile kaplanması 
yüzeye kaygan bir özellik katıp taşlaşmayı engellediği bilinmektedir. Bu sebeple 
poliüretan yüzeyin kaplama yapılacağı malzeme yüksek hidrofiliteye ve yüksek 
biyouyumluluğa sahip olmalıdır. Bu amaçla kullanılacak malzeme bu çalışma 
kapsamında poli(vinil pirrolidon) (PVP) olarak tespit edilmiştir. Suda ve farklı 
organik çözücülerde yüksek çözünürlüğe sahip olan PVP aynı zamandada 
mükemmel bir hidrofiliteye sahiptir. Literatürde yapılan çalışmalarda taşlaşmayı 
azalttığı bilinmektedir. 
Yukarıda yapılan açıklamalar doğrultusunsa, bu çalışma kapsamında iki yöntemle 
poliüretan yüzey modifikasyonu gerçekleştirilmiştir. İlk olarak poliüretan yüzeyini 
modifiye etmek ve reaktif merkezler oluşturmak amacı ile  plazma muamelesi 
uygulanmıştır. 
Plazma teknolojisi son zamanlarda yüzey modifikasyonu için en çok kullanılan 
yöntemlerden biridir. Bunun en önemli sebebi ise, plazma ile aktifleştirilmiş 
yüzeylerde organik atık malzemenin kalmayışı ve bu sebeple yöntemin çok temiz 
olmasıdır. Amaç biyomedikal bir malzeme üretmek olduğu için, atıksız bir çalışma 
büyük bir meseledir. Bu özelliğinin yanı sıra plazma, kuru uygulanan, kimyasal 
olarak yüzeyi modifiye etmek için biyolojik olarak uyumlu olan ve uygulaması kolay 
olan bir yöntemdir. Plazma uygulaması ile aktifleştirilmiş polimerlerin kütle 
özellikleri değişmez, yüzey enerjileri yani ıslanılabilirlikleri artar, biyo 
uyumlulukları artar, yüzey kırılganlıkları azalır ve kaplama için uygun hale 
gelirler.Plazma reaktif grupların karışımı olmakla birlikte, bu grupların en önemli 
davranışları yüklü bir dengede bulunmalarıdır. Yüklenmiş olan reaktif grupların 
polimerin yüzeyine uygulanması ile yüzey aktifleştirilmesi sağlanılır.  
Yüzey modifikasyonu uygulaması için ikinci bir yöntem olarak kimyasallar ile 
muameledir. Bu yöntem uygulaması için, başlatıcı özelliği olan bir kimyasal ile 
yüzeyde aktif merkezler oluşturulması ve çapraz bağlayıcı etkisi olan bir kimyasal ile 
de kaplama yapılacak malzemenin yüzeye çapraz bağlanması sağlanılır.  
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Poliüretanın modifikasyonu için yüzey modifikasyonu dışında, farklı bir polimer ile 
karışım yapılması uygulaması da söz konusudur. Karışım uygulaması poliüretanın 
morfolojisini değiştirmekte birlikte yüzey özelliklerini çok fazla etkilemediği 
bilinmektedir. 
Bu çalışmada, ticari bir termoplastik poliüretan (TPU) olan Catbothane™ PC-
3595A-B20 polikarbonat bazlı alifatik bir termoplastik poliüretanstent malzemesi 
olarak kullanılmıştır. TPU yüzeyine hidrofilik kaplama uygulaması için iki farklı 
teknik uygulanmıştır. İlk teknik plazma ile kaplamadır ve bu iki basamakta 
uygulanmıştır. İlk basamakta, TPU filmler belirli güç ve zamanda (50W, 10 dk) 
argon plazmaya maruz bırakılmış, temiz ve reaktif yüzey elde edilmiştir. İkinci 
basamakta, aktifleştirilmiş TPU filmler farklı derişimlerdeki (%5-100) PVP 
çözeltilerine 15 dakika boyunca batırılmıştır. Her TPU filmi çözeltiye batırma işlemi 
art arda iki kez uygulanmıştır. TPU yüzeyini kaplama için ikinci teknik kimyasal 
muameledir. Bu ikinci teknik de iki basamakta uygulanmıştır. İlk olarak TPU filmler, 
%8 kümin hidro peroksit ve %10 etilen glikol dimetakrilat içeren toluen çözeltisine 5 
dakika boyunca batırılmıştır. Kümin hidro peroksitin başlatıcı etkisi sayesinde TPU 
filmlerin yüzeyinde reaktif gruplar oluşmuştur. Bu basamaktan sonra, aktifleştirilmiş 
TPU filmler farklı derişimlerdeki (%5-100) TPU çözeltilerine 15 dakika boyunca 
batırılmıştır. Batırma işlemi iki kez uygulanmıştır.  
Çalışmada artan PVP konsantasyonunun TPU yüzeyindeki kaplamaya olan etkisi 
araştırılmıştır.Modifikasyonda yüzey kaplaması dışında, bir başka yöntemde TPU-
PVP karışımının hazırlanmasıdır.Bunun için, N,N-dimetil asetamid çözücüsü ile 
TPU ve PVP ayrı ayrı çözülmüş daha sonra çözülerek, biri diğerinin üzerine 
eklenerek karıştırılmıştır. Daha sonra çözücü uzaklaştırılmış ve TPU-PVP karışımı 
elde edilmiştir. 
İdrarın kaplanmış ve kaplanmamış TPU filmleri ve TPU-PVP karışımı üzerindeki 
etkisini araştırmak için, örnekler 37 oC’de sentetik idrar çözeltisinde iki hafta 
boyunca çalkalama işlemine tabi tutulmuştur.  
Kaplanmış TPU filmlerin belirlenmesi ve kaplamanın kanıtlanması için, temas açısı 
ölçümleri, Fourier transform infrared spektroskopi (FT-IR), diferansiyel taramalı 
kalorimetre (DSC), ısıl gravimetrik analiz (TGA) uygulamaları yapılmıştır. Sentetik 
idrar çözeltisinin kaplanmış ve kaplanmamış TPU filmleri üzerindeki etkisini 
araştırmak üzere Atomik kuvvet mikroskobu (AFM) ile incelemeler yapılmıştır. 
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1. INTRODUCTION 
A biomaterial is any material, whether it is natural or man-made, compatible with a 
living structure. Biomaterials are designed to be implanted into living systems to 
undertake the functions of  organs or tissues [1]. Biomedical devices are used for the 
un-functionized part of human body, and thus, they should possess biomaterial 
properties. Biomedical devices have a variety of base materials such as polymers, 
metals, composites, natural materials and ceramics. The metals have high stability 
and they are easy to sterilize but they can easily oxidize in the body. Ceramics, 
composites and natural materials are highly biocompatible but they are hard to 
process and give a shape. On the other hand compared with metals, polymers do not 
get corroded into the body, they can be synthesized in differing forms to be usefull 
for various applications, they are easy to process and give a shape, and they are 
generally similar with natural tissues, so that means they can be highly 
biocompatible.  For this reasons polymeric materials are the most widely used ones 
in biomedical industry. Polymeric biomaterials have a benign function such as, being 
used for cardiovascular or urinary catheters or stents, heart valves, prosthesis, 
controllable drug release systems, skin repair devices or contact lenses [11]. For 
materials to be biomedical devices, they should possess some qualifications to be 
used in living systems. They should be biologically compatible, non-toxic and non-
carcinogenetic, chemically inert and stable, mechanically durable, have a proper 
weight and density, highly compatible with blood, have similar properties with 
human organs and tissues, have elasticity and mechanical durability. The polymeric 
biomaterials that have these general properties are used in the field of biomedicine 
[12]. 
A number of polymers exist that have biomaterial possessable properties. Out of 
these polymeric materials, polyurethanes (PUs) have the most attention to be used as 
biomedical devices. PUs have been used frequently as biomedical devices for various 
types of applications and the research for developing properties of polyurethanes 
continues. PUs have magnificent properties such as, high compatibility with blood 
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and tissue, proper mechanical properties to be used as implants, chemical inertness 
into human body. They find place in biomedical field as vessel prosthesis, blood 
filters, catheters and heart valves [7-13]. 
Like other materials, biomedical grade polymers might need modifications according 
to be much more compatible with biological environment. For urological 
implantation, the surface of the polymer to be used as ureter stent continuesly 
contacts with urine. Thus, the polymer surface should be resistant to chemicals into 
the urine [14].  For PU, the permanent contact with urine can cause microbial film 
formation and encrustation onto the surface [13]. The surface modifications of PUs 
are known to be highly effective for this matter. Coating the surface of the PU with a 
hydrophilic polymer and making the surface lubricant is known to lower encrustation 
[6-8]. For modify and coating polymer surface, plasma modification and treatments 
with other chemicals are known and effective methods. With modified surfaces, 
more developed and compatible environments can be achieved without affecting the 
bulk properties [8-15]. 
In this work, a commercial thermoplastic polyurethane – Catbothane™ PC-3595A-
B20polycarbonate-based aliphatic thermoplastic polyurethane (TPU) – was used as a 
base polymer substrate for the modifications. For the hydrophilic coating of the TPU, 
two kinds of coating techniques were used. Firstly plasma treatments have been 
performed in two steps. In the first step, by exposing the TPU films in a certain force 
and time (50W, 10 min) with argon plasma clean and reactive surfaces have been 
achieved. For second step, the activated TPU films were dipped into various 
concentrations (%5-100) of PVP solutions for 15 minutes. The dipping process has 
been applied for two times. The second technique to coat the surface of the TPU is 
chemical treatment. This second technique was performed in two steps also. Firstly 
the TPU films were dipped into a toluene solution containing %10 ethylene glycol 
dimethacrilate and %8 cumene hydro peroxide for 5 minutes. With the help of 
cumene hydro peroxide -that has an initiator specialty- reactive species occured on 
the surface of the TPU films. After first step, the activated TPU films were dipped 
into various concentrations of PVP solutions (%5-100) for 15 minutes. This second 
step was also applied for two times. The effect of the increasing PVP concentration 
on the coating has been researched. Other than coating the surface of TPU, the blend 
of TPU and PVP has been prepared to research and compare the blend morphology 
and surface properties with the coated TPUs. For this purpose, the blend of %5 PVP 
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and %95 TPU has been prepared with solvent evaporation. N,N-dimethyl acetamide 
was used as solvent. Both TPU and PVP were dissolved seperately into the solvent 
and then the dissolved polymers were mixed with each other at constant mixing with 
magnetic stirrer. After the mixing, the solution was cast into a petri dish and the 
solvent has been evaporated. After evaporation the blend has been achieved. 
 After the coating and blend procedure, to research the effect of the urine on the 
coated, uncoated and blended TPU films, the films were dipped in an artificial urine 
solution and placed on a shaker at 37 
o
C for two weeks.  
To characterize the coating and blending contact angle measurements, Fourier 
transform infrared spectorscopy (FT-IR), differencial scanning calorimmetry (DSC), 
thermal gravimmetric analysis (TGA) was used.  The effect of the artificial urine on 
the coated, uncoated and blended TPU films were examined with Atomic force 
microscope (AFM). 
1.1 Purpose Of Thesis 
Ureteral stents are synthetic polymeric biomaterials generally fabricated from 
polyurethanes (PU), silicones or polycaprolactones. PUs have magnificent properties 
such as biocompatibility, high mechanical strength and tissue and blood 
compatibility; in this study PU is the base polymeric material to use as ureteral stent. 
Although PUs have all these properties, the surfaces of them are subjected to 
encrustation and bacterial growth in body. As with implanted biomaterials, the 
problem of encrustation leading to device-related obstruction is associated with the 
use of urethral stents. Encrustation associated with implanted biomaterial is caused 
by its permanent contact with the urine. (Coating inhibitors, urethral stent bio film, 
PU stent risks) Crystals and deposits consisting of the ionic and organic components 
of urine cover the surface of the polymer. Encrustation does not only cause to 
obstruction but also causes to infections. In according to prevent encrustation from 
covering the surface of the stent, PU surface needed to be modificated and coated 
with a more hydrophilic polymer to be more lubricious. In order to modify the 
surface, there are several options to choose. In this study, plasma modification and 
chemical treatments were chosen to modify the surface of the PU. Plasma 
modification is a highly clean, biologically compatible and effective method to coat 
the polymer surface. Chemically treating the PU surface, with reactive species 
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occurring onto the surface, coating with a more hydrophilic polymer becomes real. 
Poly(vinyl pyrrolidone) (PVP) has been chosen as coating polymer of PU surface. 
The main purpose of this thesis is to coat the PU surface with a hydrophilic polymer 
via plasma and/or chemical methods in order to prevent encrustation. 
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2.  THEORY 
2.1 Biomedical Polymers 
Natural or synthetic origin biopolymers are highly useful in biomedical applications, 
due to their biocompatibility and degradation characteristics. These types of 
biopolymers are called biomedical polymers [16]. Whether they are man-made or 
natural, biomedical polymers are in the interest of medical industry to direct, 
supplement or replace the broken, sick or injured parts of the human body [1-2-12]. 
Their acceptance to use is a time proven process of trial.  
Polymers in the form of elastomers and plastics have improved the quality of life 
over the last three decades. From the year 1855, the initiation of the polymers into 
medicine, they have achieved tremendous diversity today in use and application. 
From simple disposable syringes and baby nursing nipples to artificial heart valves 
and intraocular lenses. The biomedical polymers can also be used as sutures, bone 
plates, joint replacements and dental implants as artificial parts of human body [12]. 
Except all these examples of biomedical materials, a very important class of implants 
for human body should be stents. Stents can beused for the different parts of the 
human body, from cardiovascular to ureteral systems. Thus polymeric stents are in a 
significant interest of medicine. 
2.2 Stents 
Blockage of the tubes, arteries or ducts of human body can dependently lead to 
occlusion which induces serious diseases. To prevent these kinds of diseases and 
eliminate these blockages, a material is used call stent. Stent is a tube inserted into a 
natural path in the human body to prevent a disease induced, localized flow 
constriction [17]. 
The history of the stenting procedure dates back to 1929 when a German scientist Dr. 
Werner Forssman advanced a catheter into his heart to prove that stenting could be 
done safely [18]. After that, in 1964 Dr. Charles Dotter in Portland, used catheters to 
open blockages in peripheral arteries. In 1994 the first stent was approved by the 
Food and Drug Administration (FDA) for use in the United States [19].  
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The stent types can be varied according to their usage for differing part of the human 
body. The most used ones are explained below. 
2.2.1 Coronary stents  
The usage of coronary stents stands for the occlusive cardiovascular diseases 
including hypertension, atherosclerosis and restenosis. They can be dealed with the 
temporal pathological processes which involve blood coagulation, inflammation, 
proliferation/migration of smooth muscle cells, and endothelialization [20]. To 
resolve this problems, drug-eluting coronary stents, composition of bare metal stents, 
polymer coatings and drugs, are widely used clinically to treat coronary 
atherosclerosis and have been shown to reduce in-stent restenosis. After coronary 
stenting, metallic stents causes restenosis and needs to be repeated surgical 
procedures [21]. To overcome several problems of conventional metallic stents, a 
drug-eluting polymeric matrix system should be coated through the entire metallic 
surface [22]. In the Figure 2.1. (a) a metallic stent placed into the artery can be seen. 
The stent has cleared the obstructed area. As mentioned, the polymer-coated metallic 
stents are trend for these days. In the Figure 2.1. (b) a polymer-coated metallic stent 
can be seen.  
 
 
(a)                                                               (b) 
Figure 2.1: (a) A coronary stent placed into the artery, (b) A polymer-coated 
metallic coronary stent 
2.2.2 Ureteral stents  
Ureteral stents are urological medical devices that are designed to provide an 
unobstructed urine flow from the renal pelvis to the bladder and from the bladder 
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through the urethra [23]. They are synthetic polymeric biomaterials used extensively 
in the upper and lower urinary tract, to facilitate urine drainage which can be seen in 
Figure 2.2. (a) and (b). In the Figure 2.2. (a) a polymeric ureteral stent can be seen 
and in the Figure 2.2. (b) the placement of the polymeric stent can be observed. Since 
the discovery of first double-J stent by Finney and Hepperlen to the urological 
society, ureteral stenting for de-obstruction of the urinary passage has become a 
routine procedure in urology.Over the time, many improvements on the ureteral stent 
design and composition material have been made according to improve the 
effectiveness of the stent. Unfortunatily, the long-term usage of the ureteral stents is 
limited by the polymeric materials adverse effects. The most common problems of 
ureteral stents are generally; stent infection, encrustation or migration, hyperplastic 
urothelial reaction and patient’s discomfort. The ideal stent should be, biocompatible 
to be compatible with human body, visibile on ultrasound to be examined after the 
procedure, easy to insert or remove for the surgical operation to be easy and comfort 
for the patient and surgeon, should not have encrustations or bacterial growth on its 
surface [24]. Amoung these, stent encrustation is the major problem that mostly met 
by exchange of the indwelling stent at regular intervals of 6-12 weeks because the 
stent may get obstructed as a consequence of encrustation.  Permanent contact with 
urine and bacterial growth are the two main individuals that causes encrustation. 
Thus it can be said that, the presence of bacterial biofilms on stent surfaces in 
combination with urine pH elevation and electrolyte composition is responsible for 
crystal formation and consequently, stent encrustation [6]. To prevent encrustation 
from covering the surface of the stent, some certain modifications must be applied to 
the surface of main polymer.  
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                                             (a)                              (b)  
Figure 2.2: (a) Picture of a polymeric urethral stent, (b) picture of the polymeric 
stent placed into the urethra. 
The most widely-used stents are coronary and ureteral stents. The rest of the stent 
kind is used less, and the rest includes, prostatic stent, which is used when a human is 
not able to urinate because the enlarged prostate pushes against the urethra and 
blocking the urine flow, esophageal stent is used to keep a blocked area open so the 
patient can swallow soft food and liquids and biliary stent is used to provide the bile 
drainage [19]. 
As explained above stents can be either metallic or polymeric. For ureteral systems, 
polymeric materials are used mostly and the reason for that is, in general, polymers 
appear to be more inert in nature than metals or other substances. Since there is no 
metallic stent is needed for ureteral systems, the kind of the synthetic polymer is 
extremely important for stenting in urology [19]. Polymers that can be used as stents 
for ureteral systems are examined below. 
2.2.3 Ureteral polymeric stents 
Man-made synthetic polymers are the base material for ureteral stents. For 
biomedical polymers to be used as ureteral stents, they have to fulfill some 
requirements. As mentioned earlier, the polymer to be a stent should firstly be 
biocompatible, have good mechanical properties and be comfortable for the patient 
and surgeon. There are several kinds of polymers that can be used as ureteral device 
in human body. 
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 Poly(e-caprolactone) (PCL) is a hydrophobicand semi crystalline aliphatic 
polyester. PCL is known with its good biocompatibility and permeability for drug 
and it is used as the matrix material of the films. PCL is one of the earliest polymers 
synthesized in the early 1930s. Because of its good solubility, low melting point (59–
64
o
C) and blend-compatibility,PCL became very usefull in the biomedical field. 
Attention was drawn to this biopolymer owing to its advantages over other 
biopolymers in use at that time. These included mechanical properties, ease of 
shaping and manufacture enabling appropriate pore sizes conducive to tissue in-
growth, and the controlled delivery of drugs contained within their matrix. Although 
PCL has desirable properties for stenting, it became un-useful after 1980s because of 
the popularity and usefulness of other resorbable polymers. PCL was generally used 
to form matrix materials for drug-elution and after 1980s polylactide and 
polyglycolide kind of polymers got ahead of PCL because the studied polymers in 
applications that demanded the polymer matrix to release encapsulated drugs within 
days or weeks with a complete resorption 2–4 months after implantation. It is known 
that with increasing hydrophobicity, encrustation increases,too and since PCL is a 
hydrophobic polymer, it will need certain modifications before it can be used as stent 
[23]. 
 Poly (dimethyl sulfoxide) (PDMS) belongs to a group of polymeric organo 
silicon compounds that are commonly referred to as silicones. The first 
silicone elastomers were developed in the search for better insulating materials for 
electric motors and generators which dates back to 1940s. PDMS elastomers are 
widely-used in various biomedical applications thanks to its high oxygen 
permeability, mechanical properties, chemical and biological inertness, ease of 
fabrication, exhibiting homogenous properties and resistant to extreme environments 
and temperatures from −55 °C to +300 °C while still maintaining its useful 
properties. PDMS usage as biomedical device or implant includes, microfluidic 
devices, ophthalmologic biomaterials, artificial lungs, artificial finger joints, 
prosthesis, drug delivery systems, membranes and urological stents. In spite of these 
properties PDMS has an inherent hydrophobic surface and it tends to biofoul. Since 
these features lead to nonspecific adsorption of biomolecules, and present challenges 
for surface wetting and channel filling limits PDMS usage as biomedical device. The 
surface of the PDMS needs to be modified before it can be used as ureteral device 
[26]. 
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 Poly (methyl methacrylate) (PMMA) is a synthetic resin produced from 
the polymerization of methyl methacrylate. The discovery of PMMA dates back to 
early 1930s by British chemists Rowland Hill and John Crawford in England. As 
biomedical polymer, PMMA is being used as intraocular lenses, hard contact lenses, 
bone cement, dental filling and so on. Its rigidness, hydrophilicity and 
biocompatibility are the most important properties for PMMA to be used as implant. 
These three properties are the most desired ones for stenting. However PMMA is not 
suitable to be a stent by itself, it is more suitable to be blended or copolymerized with 
other useful polymers or to be used as a coating material [6].   
 Polyurethane (PU) is a synthetic polymer that is formed by reacting a kind of 
isocyanate with a kind of polyol. Its first discovery dates back to 1937 when Otto 
Bayer and his coworkers in Germany first made PU. Since its discovery PU is 
widely-used around the world for various applications such as, foams, thermal 
insulation materials, foot-wear materials, electric instrument bezels, leathers for 
textile industry and most importantly biomedical devices [27]. The most widely-used 
urological devices nowadays produced with polyurethane and polyurethane-based 
polymers. Thanks to the properties such as, covering from a high performance 
elastomer to tough thermoplastic, low price, superior physical properties (high tensile 
strength, abrasion and tear resistance, low temperature flexibility), high versatility in 
chemical structures, being inert at the biomaterial/tissue interface, having superior 
biomedical properties makes polyurethane highly suitable to be used as ureteral stent 
[13]. As mentioned before, for the patients comfort, the mechanical behavior and 
elasticity of the polymer is highly important [28]. Especially thermoplastic-grade 
polyurethanes are highly suitable for both comfort of the patient and ease of the 
surgery. The chemical structure of the PUs is adjustable and with changing the basic 
monomers the surface of the PUs can be in the range of hydrophilic or hydrophobic. 
With variable monomers, PUs can be hydrophilic, water-absorbable hydrogels or 
they can be hydrophobic, non-water absorbable polymers. This variable property 
gives PUs a priority to be used as stent [13]. Polyurethanes as purely, as blends and 
as copolymers have been used as ureteral stent materials in the past. Their 
mechanical, chemical and physical properties are enough to be a stent but their 
surface properties are prone to bacterial growth and encrustation [13-29-30]. This 
propensity does not prevent polyurethanes to be used as stent materials because their 
surface can be modified easily.  
  
11 
 
As described, PUs have perfect properties to be ureteral device. The only issue is 
about its surface properties. Because the surface of the PU is prone to bacterial 
growth and especially encrustation, it should be modified. Commercial PU surfaces 
are in the range of hydrophilicity but they are near to the border line of 
hydrophobicity [8]. The hydrophobicity and hydrophilicity phenomenon of the 
biomedical devices has proven to be effective on encrustation. It has been detected 
that, as the hydrophobicity of the surface decrased, the encrustation on the ureteral 
stent decreased also. To lower down or inhibit the happening of encrustation, surface 
of the PU  should have more hydrophilic characteristic [6-8]. Coating with a more 
hydrophilic material is a known and proven way to make PU surface more 
hydrophilic [8]. In case of coating the surface with more hydrophilic material, 
choosing the coat-material is a very important issue. The coating material should  be 
biocompatible like PU, it should be  highly hydrophilic and it should repel the 
bacterial colonization and encrustation.  There are some candidates for this purpose 
which are; heparin, PMMA, poly(ethylene oxide) (PEO), chitosan, poly(vinyl 
pyrrolidone) (PVP) etc. Out of these natural and synthetic materials, the most 
widely-used and most effective material for surface coating is PVP. Other materials 
have issues like, PEG is known to be susceptible to oxidation in vivo environment. 
Two problems are frequently encountered with many active substances: their low 
degree of solubility in water and their limited bioavailability. Thus, more stable 
alternatives are required like PVP [6-8-31]. 
PVP’s patent granting dates back to 1939. It was first discovered to take place of the 
blood plasma during the Warld War II by German scientists. The reason of  it’s 
discovery was to become artificial blood but, it soon was understood that PVP was 
an all-around talent not just an artifical blood. It is physiologically compatible, non-
toxic, essentially chemically inert, temperature-resistant, pH-stable, non-ionic, 
colorless and it has excellent biocompatibility and strong coordination ability. One of 
the outstanding properties of the soluble PVP products is their universal solubility in 
hydrophylic and hydrophobic solvents especially its readily-solubility in water. This 
combination of excellent properties predestined its use in medicine, pharmaceuticals 
and cosmetics. Many properties of PVP polymer derive from its pyrrolidone 
functionalitiesm [32]. The synthesis of PVP’s monomer N-vinyl pyrrolidone is 
shown is the Figure 2.3. PVP products are obtained by the radical polymerization of 
N-vinyl pyrrolidone. 
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Figure 2.3: Synthesis of N-vinyl pyrrolidone 
As a polymer soluble in both water and organic solvents, PVP has been the focus of 
numerous applications including additives, cosmetics, coatings and biomedicines and 
biomedicals. PVP is mostly used in pharmaceuticals as binder in tablets or granules 
to form a matrix system or to improve solubility and to form soluble complexes. 
Other than its usage in pharmaceuticals PVP is used as coatings for medical 
applications because, it hydrophilizes and forms pores on plastics, reduces the 
toxicity of the certain substances, stabilizes the enzymes and vitamins and it is 
resistant to protein adsorption, cell adhesion, biofilm formation and encrustation. 
This properties makes it useful for various applications such as hemocompatible 
surface-modifiers, drug delivery carriers, film formers, binders, stabilizers,  and 
bioconjugation and surface ligand immobilizations but mostly for biomedical 
devices. 
PVP is the perfect material to coat the PU surface and reduce the encrustation and 
give the final product properties like, improving material biocompatibility, 
hydrophilization and lubrication, bringing the additional possibility of the active 
agent incorporation during the coating process. Thus hydrogel modified surface have 
an advantage over unmodified one. To coat the surface of the PU with PVP, firstly 
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reactive species has to be occured onto PU surface so that PVP can chemically bond. 
For that reason, surface treatment of the PU is the first step of the coating process 
[33].  
2.2.4 Surface modification 
It is a challange to design biomaterials that fulfill all functional requirements. A 
common approach is to fabricate materials with acceptable bulk properties and then 
to modify the surface and chemical properties. Medical grade polymers like PU, PCL 
and PDMS are generally hydrophobic (low-surface energy), chemically inert and 
nonpolar surfaces which often face with protein adsorption, cell adhesion, biofilm 
formation and encrustation. For this reasons, surface modification of these materials 
become very important in medical applications [35]. There are several kinds of 
methods to modify the surface of the PU such as; grafting method, chemically 
treating method and plasma surface modification method [35-9]. Since in this thesis 
the last two methods were used for surface modification of PU, detailed explanations 
about only these methods are given below. 
2.2.5 Plasma surface modification method 
The term plasma was first introduced by Langmuir in 1928. The plasma is defined 
as, ionized gas, being ionized in a state where at least one electron is not bound to an 
atom, converting the atom into charged ions. Gaseous plasma is referred to as the 
fourth state of matter and can be envisioned as a collection of electrons, charged 
positive and negative ions, neutral species, radicals, electromagnetic radiation, 
molecules, and molecular fragments. Thus, plasma is a mixture of energetic and 
reactive species, and an important feature in their behavior is their coexistence in a 
state of charged equilibrium. The plasma process can be seen in the Figure 2.4 [36]. 
By applying an electrical potential to gas under vacuum, the gas decomposes to its 
atoms and molecules. These atoms and/or molecules are charged with the electrical 
potential and becomes ions. It is accepted that, the newly occuring space that has 
negative and positive ions is neutral. With the attack of these negative and positive 
charged ions to the substrate, activated surfaces can be achieved. 
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Figure 2.4: Scheme of plasma modificator 
Plasma technology is a very clean, dry, biologically appropriate method to 
chemically modify the surfaces. It is easy to apply, enviromentally friendly, can be 
applied in any type of facility in a clean room and most importantly it leaves no 
organic residues. Since the objective is to fabricate a biomedical device, leaving no 
residues behind is a major issue that plasma technology is successfull with. 
Therefore, activated surfaces can be achieved with plasma technology without 
affecting the bulk properties of the base polymer while, enhancing surface energy 
(wettability), improving biocompatibility, surface functionalization, reduced surface 
friction, molecular immobilization and being as a barrier surface coating [36]. 
Plasma method has been used to modify polymer surfaces for different purposes, but 
has not been used before for coating the stent surfaces with hydrophilic polymers. 
2.2.5.1  Sputtering and etching of the surface 
Applying the plasma sputtering, material removal from the surface occurs by the 
physical bombardment with atoms, molecules, excited species and with chemical 
reactions. These kinds of changes in the surface morphology and topography 
increase the surface area and play an important role for biocompatibility. Generally, 
inert Nobel gases like argon (Ar) and neon (Ne) are used for physical ablation and 
free radical generation for further chemical reactions. By etching the surface with 
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plasma, the surface chemistry of the substrate changes and micrometer or nanometer 
scale surface features occurs (e.g., pores, pits, or protrusions). In Figure 2.5 this 
phenomena can be seen. Such patterns are used to coat the surfaces with various 
chemical gradients. While activating the surface, the bulk properties of the base 
polymer does not change. This specialty is one of the most important parameter for 
biomedical polymeric materials [36].  
 
 
Figure 2.5: Process of sputtering and etching of the surface 
2.2.5.2 Functionalization 
In order to coat the surface of the polymeric devices, the surfaces have to be 
functionalized firstly. The use of inert gases like Ar, Ne and helium (He) is known to 
introduce active sites through radicals and further chemical reactions can be initiated 
on this reactive layer. After plasma treatment, exposing the polymer substrates to 
strongly oxidizing gases such as O2 and athmospheric air remove organic 
contaminants and generate reactive O2 species at the surface such as peroxides or 
hydroperoxides.  
Compared to the other nobel gases, Ar is the low-cost gas and for that it has been 
used for plasma commonly. The mechanism of the reactive-surfaced polymers 
achievement by applying Ar plasma is shown in Figure 2.6.     
 
Figure 2.6: Activation of the polymer surfaces 
Plasma treatment has an affect of increasing the surface energy but this affect is not 
permanent, it lasts for a certain amount of time. The reason for that is, the oxygen 
atoms that bonds to the activated groups of the surface is released by the surface 
molecules in time [36-9]. 
 
  
16 
 
2.2.6 Chemical treatment method 
The surfaces of polymeric materials can be modified and active species can be 
occured onto the surface with the help of certain chemicals. When free radicals are 
generated onto the surface, further initiation with other chemicals could be done and 
this makes coating possible. Generating free radicals onto the surface is linked to 
radical polymerizarion [8]. The mechanism of radical polymerization for ethylene 
monomer can be seen in the Figure 2.7.As seen from the mechanism, in the first step, 
free radical initiator-kind chemical generates radicalic species onto the monomers for 
further chemical reactions. The same mechanism can be applied to the polymer 
surface and the initiator-kind chemical generates free-radicals onto polymeric 
surfaces as can be seen in the Figure 2.8. For this modification method the initiator 
that makes free-radicals is important.  
 
 
Figure 2.7: Mechanism of radical polymerization 
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Figure 2.8: Chemically modifying the surface of polymer 
2.2.6.1 Free radical initiators 
Radical initiators are the substances that can produce radical species under mild 
conditions and promote further radical reactions. Initiator type chemicals have weak 
bonds that can readily dissociate because of the weak energies they have. Organic 
and inorganic compounds can be used to generate radicals that initiate 
polymerizations. Two most common classes of initiators are peroxide and azo 
compounds. Organic peroxides each have a peroxide bond  (-O-O-), which is readily 
decomposes with dissociation of this bond and cleaved to give two oxygen-centered 
oxyl radicals which are rather unstable and believed to be transformed into relatively 
stable carbon-centered radicals. The following mechanism of decomposition is 
proposed for peroxides and can be seen in Figure 2.9 [37]. 
 
Figure 2.9: Decomposition mechanism of peroxides 
Such examples like, di-tert-butyl peroxide, benzoyl peroxide, methyl ethyl ketone 
peroxide and cumene hydroperoxide (CHP) are the examples of organic peroxides. 
CHP is   a reagent that is used to produce organic peroxides. The decomposition 
products of CHP are methylstyrene, acetophenone, and cumyl alcohol.  CHP is 
prepared from the oxidation of cumene with air at a high temperature. The industrial 
applications include the production of polymers and fiberglass products.  
According to the coating procedure with chemicals, the coating material should be 
bonded to the surface with covalent cross-linking, otherwise the coating could not be 
stable [38]. 
2.2.6.1.1 Cross-linking and cross-linking agents 
Cross-linking is the formation of chemical links between molecular chains to form a 
three-dimensional network of connected molecules. The covalent cross-linking is 
used to control and enhance the properties of the resulting polymer systems such as 
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thermosets or coatings [39]. In according to have a thermoset polymer, cross-linking 
agents can be added to the system during the synthesis. To use the cross-linkers for 
coatings, these materials can be added to the system after synthesis of the polymer, 
according to cross-link the coating material to the base polymer surface.  Examples 
of cross-linking agents are, ethylene glycol di(methacrylate) (EGDMA), 
methylenebisacrylamide, formaldehyde and etc. EGDMA is a hydrophilic 
difunctional methacrylate offering low viscosity, adhesion, flexibility, and high 
cross-link density. Incorporation of EGDMA into polymeric resins improves their 
mechanical properties such as impact strength and abrasion resistance. EGDMA is 
known to be used in free radical polymer cross-linking reactions [40].  
2.2.7 Contact angle measurements 
The contact angle phenomenon lies in the interaction between a solid and a liquid. 
The quantitative evaluation of the wetting of a solid by a liquid is made in terms of 
the contact angle. As can be seen in Figure 2.10, the angle (θ) between liquid drop 
and the solid surface is the main phenomena for this topic [41]. 
 
Figure 2.10: Schematic diagram of the contact angle phenomenon [41] 
The most important relation for the contact angle measurements is the Young’s 
equation that relates the contact angle θ, liquid surface tension γl, solid surface 
energy γs, solid-liquid surface tension γsl as expressed in (2.1). 
γ1cosθ=θsγγsl 
                                (2.1)  
The surface tension is closely related to the surface wettability which is highly 
related to biological environment. The hydrophilicity/hydrophobicity characteristic 
of the surfaces are directly linked to surface wettability and contact angle 
measurements gives direct informations about the surface wettability.  Contact angle 
measurements not only gives informations about wettability but also gives 
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informations about roughness, molecular orientation and swelling properties. There 
are several kinds of contact angle measurement methods, for this thesis sessile drope 
method is used in experimental study [41]. 
2.3 Literature Rewiev 
Polyurethanes have been extensively used as polymeric biomedical devices in 
ureteral systems and there are several studies about that topic in the literature. In this 
chapter, some of them which are achieved for the surface modification and coating 
are summarized and experimental results which is related to this thesis are discussed. 
Tunney et. al.investigated the surface properties of PVP-coated and uncoated 
polyurethanes and compared to each other in view of the lubricity, ability to resist 
bacterial adherence and encrustation happening. In that work, polyurethane and PVP-
coated polyurethane have been obtained commercially. The PVP coated PU 6 French 
diameter biomaterial sections fromMenlo Care Inc., California.The contact angle of 
untreated polyurethane was found to be about 93
o
. This value was decreased to 
almost 50
o 
for PVP-coated polyurethane. Scanning electrone microscope (SEM) 
studies showed that, after 6 weeks of encrustation, the surface of PVP-coated 
polyurethane was only partially covered by encrusting deposits. In contrast, the 
surface of the uncoated polyurethane was almost completely covered with encrusting 
deposits at the same period. Atomic force microscopy results showed that, the 
amount of magnesium andcalcium deposited on the surface of polyurethane was 
significantly decreased after PVP coating [25]. 
Butruk et. al. used a simple method named “Fenton type reaction” for coating the 
polyurethane surface with PVP. The coating is formed due to free radical molecular 
grafting and crosslinking. For that purpose, the polyurethane surface was first 
immersed in an organic solution which contains a free radical source and a branching 
and an anchoring agent. After occuring of free radicals onto the polyurethane 
surface, the substances were immersed in a water solution that containing PVP. Two 
kinds of PVP, PVP 360 (molecular weight: 360.000 g/mol) and PVP 24 (molecular 
weight: 24.000 g/mol)  were used. The authors claims that, the novelty of this 
process consists in the fact that free radicals are formed mostly at the 
polymer/solution interface, what assures high grafting efficiency together with the 
formation of covalent bonds between polymer substrate and modifying layer. Surface 
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was investigated by attenuated total reflectance Fourier transform infrared (ATR FT-
IR) measurements and the surface wettability of the samples was determined by 
contact angle measurements. FT-IR measurements have indicated  the absorbance 
peaks belongs to PVP’s C=O stretching and C-N stretching for the analysis of 
coated-polyurethane samples. The advancing contact angle of coated polyurethane 
with PVP 360 and coated polyurethane with PVP 24 were 82
o
, 72
o
 and 28
o
, 
respectively. Thus, hydrophilic and lubricious surfaces had been achieved with 
coating of PVP 24 onto the polyurethane substrate [8]. 
Liu et. al., studied a facile PVP immobilization with plasma technique. Surface 
modification of polypropylene microfiltration membrane (PPMM) by PVP were 
done. That work involved the physical adsorption of PVP, followed by a plasma 
treatment to immobilize PVP on the membrane surface. For the experimental part, 
the PPMMs were dipped into the PVP solution, dried and than radiation with air 
plasma at 30 W and at 10 Pa was executed onto the surfaces of the substrates. ATR 
FT-IR analysis showed that compared to the PVP-modified membranes with the 
unmodified ones, a new peak appeared at 1660 cm
−1
, which is corresponding to the 
typical absorption of carbonyl group in the pyrrolidone ring of PVP. Another new 
peak at about 1260 cm
−1
 was ascribed to the stretching vibration of C-N bond [10]. 
Kessler et. al., reported that a biocompatible polycarbonate (PC) membrane was 
treated with plasma argon in order to improve its surface properties. The purpose of 
that work is to reduce the surface hydrophobicity by fixing PVP at the surface. In the 
experimental part, a commercial polycarbonate membrane was used. The activated 
PC membranes were dipped twice into the PVP solution. The contact angle results 
showed that, PCM surface treatment increased its hydrophilic properties, as well as 
its wettability. The contact angle with water decreased from 47
o
 to 20
o
 after surface 
treatment and PVP coating. (coating with PVP after plasma treatment) 
Zhou Yuan et. al. studied the effect of PVP when blended to poly(vinylidene 
fluoride) (PVDF)/Thermoplastic polyurethane (TPU) blend with the help of N, N-
dimethylacetamide (DMAc). The effect of hydrophilic additive, 
polyvinylpyrrolidone, on the morphology and crystal structure of PVDF/TPU blends 
membranes was studied. Molecular weight of PVP was 30.000 g/mol (PVP 30) used. 
PVDF/TPU blends were made by phase inversion method. For this, PVDF/TPU was 
dissolved in DMAc and PVP was dissolved with DMAc seperately and the two 
solutions blended with each others. In order to characterize the new blended 
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polymer, ATR FT-IR and differential scanning calorimetric (DSC) were used.After 
the blended polymer is achieved, characterization of the polymer were done. FT-IR 
spectra showed that, the peaks that belongs to PVDF at 795 and 976 cm
-1
 decreased 
with increasing PVP amount. That revealed that crystallinity of the PVDF in 
membranes reduced with increasing PVP content. This result was supported by DSC. 
Khandwekar et. al., researched the poly(vinyl pyrrolidone)-iodine (PVP-I) 
engineered polyurethanes as urinary medical devices. They used a commercial 
polyurethane and PVP-I complex. In order to engineer the polymer surface, PVP-I 
was dissolved in de-ionized water and then tetrahydrofuran (THF) was added to this 
solution. Polyurethane films were then dipped into this solvent/nonsolvent mixture. 
Exposure of the polymer to THF in the absence of macromolecules resulted in much 
faster polymer–solvent interaction. From FT-IR peaks, PU/PVP-I showed 
appearance of a new carbonyl stretching peak at 1662 cm
-1
 region which was not 
visible on uncoated PU surface. This peak is a mixed mode containing contributions 
from the C=O (amide II) stretching and N–C stretching vibrations of PVP-I 
molecules in PU/PVP-I films. According to the dynamin contact angle study, the 
advancing contact angle of uncoated polyurethane and PU/PVP-I films were 91
o
 and 
46
o
, respectively. SEM revealed that, after 2 weeks of encrustation the surface of 
PVP-I modified PU was only partially covered with encrustation, the surface of 
uncoated PU was almost completely covered with encrustation deposits [13].  
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3.  EXPERIMENTAL 
3.1 Used Chemicals And Their Properties 
The thermoplastic polyurethane (TPU) used as polymer substrate is a commercial 
polymer named Carbothane TPU - PC-3595A-B20 which is a polycarbonate based-
aliphatic polymer. It has %20 of barium sulfate in its composition to make the 
polymer visible under UV light. Some properties of this polymer are given in the 
Table 3.1. 
Table 3.1: Properties of Carbothane TPU 
Properties Value 
Specific gravity, g/ml(20
o
C) 1.05  
Appearance                 White pellets 
 
Sigma-Aldrich brand poly(vinyl pyrrolidone) (PVP) was used as the coating 
substrate. The molecular structure of the PVP is given in Figure 3.1. Two kinds of 
PVP,PVP 360 and PVP 40, were used in this study. Some specifications of PVP are 
given in Table 3.2. 
 
Figure 3.1: Moluecular structure of PVP 
Table 3.2: Properties of PVP 360 and PVP 40 
 PVP 360 PVP 40 
Properties Value Value 
Molecular Weight, g/mol 360.000 40.000 
Specific gravity, g/ml(20
o
C) 1,29  1,23  
Appearance White powder White powder 
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Other chemicals to activate the surface of the TPU are Sigma-Alrich brand ethylene 
glycoldimethacrylate (EGDMA) and cumene hydroperoxide (CHP). The molecular 
structures of EGDMA and CHP are given in Figure 3.2 (a) and (b). Some 
specifications of them are given in the Table 3.3. 
 
                                                            (a)                                              (b)  
Figure 3.2: Molecular structure of (a) EGDMA and (b) CHP 
Table 3.3: Properties of EGDMA and CHP 
 EGDMA CHP 
Properties Value Value 
Molecular weight, g/mol ~198 ~152 
Specific gravity, g/ml(25
o
C) 1,08 1,03 
Appearance Colorless liquid Colorless liquid 
 
3.2 Modification of the surface of the TPU films 
3.2.1 Surface treatment by plasma 
PVP coating of TPU films by plasma were performed in two step dip-coating 
method. Surface activation was achieved by glow-discharge plasma generator with 
argon atmosphere under vacuum. For this, Diener electronic brand Pico-LF-RF 
plasma modification device was used (Figure 3.3.).The plasma reactor has a pair of 
copper electrodes. These two electrodes were powered through a matching network 
by a 13.56 MHz radio-frequency (RF) [34]. 
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Figure 3.3: Diener electronic brand Pico-LF-RF device 
The TPU films were put horizontal in the middle of plasma chamber and both sides 
of the films were exposed to plasma treatment. The chamber was vacuumized to 0.3 
mbar and kept constant at this value by a pressure regulator connected with the 
plasma chamber. The electrical discharge was maintained during 10 minutes with 50 
W emission power. Then plasma was generated. The TPU films were activated by Ar 
bombardment and the active radical sides were produced onto the surface. Then the 
TPU films were exposed to air for 20 minutes for the epoxide groups to occur onto 
the surface. Second step was performed at air by dipping the activated TPU films in 
of aqueous PVP solutions. After two dipping the TPU films were dried at 50
o
C under 
vacuum. In order to investigate the effect of PVP concentration on film performance, 
PVP solutions were prepared in various concentrations between 5-100%, w/v. The 
samples were designated using the accreviation TPU-PVP-a-p, where a indicates the 
type of PVP. 
3.2.2 Surface treatment by chemicals  
PVP coating of TPU films with chemicals were performed in two step dip-coating 
method. In first step, the TPU films were immersed in a toluene solution containing 
10% EGDMA and 8% CHP for 5 minutes at room temperature. In the second step, 
the TPU films were dipped in a water solution containing given amounts of PVP (5-
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100%), 0,1% FeCl2 and 1%ascorbic acid (AA) (w/v) for 15 minutes at room 
temperature. Ascorbic acid prevented Fe
2+
 ion oxidation by air during the process 
and was also responsible for reduction of Fe
3+
 ions produced during the Fenton 
reaction [8]. After two dipping into the PVP solution, the TPU films were immersed 
in 0,1 Sodium dodecyl sulfate(SDS) (w/v) and placed on a shaker for 5 minutes for 
the unbounded PVP to remove. Finally, polymer films were rinsed in Phosphate 
buffer solution(PBS) solution and dried at 50 
o
C under vacuum. The samples were 
coded as TPU-PVP-a-c, where a indicated the type of PVP. 
3.2.3 Mechanism of reaction 
A system containig CHP, FeCl2 and AA was used for the occuring of free radicals. 
CHP is a source of free radicals initiated by the redox reaction with Fe
+2
. AA is used 
to maintain the iron ions in the ferrous form [8]. The reaction mechanism can be 
examined in the  Figure 3.4. 
 
 
 
Figure 3.4: Reaction mechanism of radical initiation and PVP coating [8].  
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3.3 Blending TPU With PVP 
TPU-PVP blend was prepared with solution evaporation method. The solid rate of all 
solutions was adjusted to 10%(w/w). The amount of PVP  in TPU-PVP blend 5% 
(w/w). Firstly, both TPU and PVP were dissolved seperately in N,N-
dimethylacetamide at 70
o
C with constant stirring.  After both of the polymers were 
dissolved, they were mixed together at 70
o
C and stirred about 4 – 5 hours. Polymer 
solution was cast into a petri dish and solvent was evaporated under vacuum. The 
samples were coded as TPU-PVP 360-b and TPU-PVP 40-b [10]. 
3.4 Characterization Methods 
3.4.1 Contact angle measurements 
The hydrophilicity of the coated and uncoated TPU films was measured by the KSV 
CAM200 brand contact angle measurement device. With sessile drop method the 
volume of the drop that is used in the experiments was adjusted to 5-6 µl.  
For each polymer film the measurements were performed for 10 times for 5 different 
batches before and after coating.  
3.4.2 Differential canning calorimeter  
The thermal properties of the polymers were measured by Perkin Elmer 4000 
differential scanning calorimeter (DSC) brand device under nitrogen atmosphere. 
Analyses were done between 30
o
C to 240
o
C at 10
o
C/minute scanning rate. 
3.4.3 Thermal gravimetric analysis 
The gravimetric thermal behaviors of polymers were analyzed by Perkin Elmer 4000 
thermal gravimetric analyzer (TGA). The experiments were done under nitrogen 
atmosphere from 30
o
C to 500
o
C at 20
o
C/minute heating rate.  
3.4.4 Atomic force microscope 
In this work, Nanomagnetics Instruments – ezAFM brand AFM was used.To 
investigate the coating and encrustation happening onto polyurethane surface, 
surface properties like phase seperation and topology were examined with an atomic 
force microscope (AFM). The measurements were done with tapping mode for 
80x80 µm area.The measurements were done to coated polymers that were rinsed 
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with SUS to examine the encrustation. After examining the SUS rinsed polymers, 
this polymers were washed to see the topology and phase seperation without 
encrustations onto the surface. 
3.4.5 Swelling properties of polymers 
The swelling properties of the coated and uncoated polyurethane samples were 
researched in phosphate buffer solution (PBS) according to ISO D570 standards. The 
samples were firstly dried into oven for 24 hours. After that, the samples were left in 
the desiccators for another 24 hours for the equilibrium to be achieved then the 
samples were dipped into the PBS solution for 4 days at 37
o
C. After 4 days, the 
surfaces of the samples were dried gently and the weights of the samples were 
measured. In order to calculate the swelling ratio of the samples (3.1) is used. After 
removal PVP from the surface, polymer was dried and its contact angles 
measurements was determined. 
Swelling Ratio (%)  2 1
1
.100
W W
W

  
W1 = Weight of coated dry polymer (g) 
W2 = Weight of coated swollen polymer (g) 
(3.1) 
3.4.6 Encrustation properties of polymers 
Synthetic urine solution (SUS) contains, (g/L) CaCl2.2H2O, 0.651; MgCl2.6H2O, 
0.651; NaCl, 4.6; Na2SO4, 2.3; KH2PO4, 2.8; KCl, 1.6; NH4Cl, 1.0; urea, 25.0; 
creatine, 1.1; and tryptic soy broth, 10.0.This formula of the urine is equivalent to 
original human urine within 24 hour period [40]. Before experiments, the surface 
properties of the polymers were examined with atomic force microscope (AFM) then 
the polymers were dipped into the SUS and placed on a shaker at 37 
o
C for 2 weeks. 
After 2 weeks the surfaces of the polymers were examined with (AFM) to investigate 
the crystal deposit gathering onto the surfaces of samples.  
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4.  RESULTS AND DISCUSSION 
4.1 Characterization Of Uncoated TPU And PVP-Coated TPU Structure 
4.1.1 Fourier transform infrared spectroscopy 
In order to characterize the structure of TPU and PVP-coated TPUs, Fourier 
transform infrared (FT-IR) spectroscopy were used. The FT-IR spectrum of all 
samples are given in the Figure 4.1, and the characteristic peaks of TPU and PVP are 
given in the Table 4.1. The –CH groups of both PVP and TPU are at about 2910 and 
2850 cm
-1
. For this reason, this peak is not usefull to prove the existance of PVP for 
PVP coated TPUs. The peak of C=O stretch at about 1660 cm
-1
 is the characteristic 
peak of PVP. For all PVP coated and blended TPUs, a peak at about 1660 cm
-1
 is 
observed which is a prove of PVP existance. 
Table 4.1: Wavelengths of functional groups 
Functional Group Wave length (cm
-1
) 
-CH 2927 for PVP 
-CH 2857 for TPU 
-NH 3335 
-CN 1520 
C=O 1660 
  
Khandwekar A.P. reported that, the FT-IR spectrum of PU/PVP-Iodine showed a 
new carbonyl stretching peak at 1662 cm
-1
 that was not visible on the uncoated 
polyurethane surface [13]. Butruk et. al. reported that, in their spectrum 
corresponding to PVP-grafted polyurethane, absorption peaks at 1650 cm
-1
 
corresponds to C=O stretches of PVP [8]. As mentioned above, in our work, 
absorptions peaks near to 1660 cm
-1
 was observed for all PVP-coated polymers. 
Thus, it can be concluded that, coatings were successfully achieved.
  
30 
 
 
 
Figure 4.1: FT-IR spectrum
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4.1.2 Differential scanning calorimeter 
The glass transition temperatures (Tg) of the polymers were measured by differencial 
scanning calorimeter (DSC). The Tg values of TPU and PVP are given in Table 4.2. 
Since TPU and PVP have different Tg values, the PVP coating onto the TPU surface 
can be proved by DSC results. DSC curves of the samples are given in Appendix C. 
TPU gives a Tg at the first cycle of measurement. On the other hand, PVP gives a Tg 
at the second cycle of measurement. 
Table 4.2: The Tg values of PVP and TPU with measurement of DSC 
Code 
Glass Transition Temperature 
 Tg (
o
C) 
TPU 76 
PVP 40 171 
PVP 360 176 
   
DSC curve of TPU-PVP-40-p is also given in Figure C.4 and Figure C.5 in Appendix C. 
The Tg value of TPU was detected around 86 
o
C in the first cycle and, the Tg value of 
PVP were detected around 190 
o
C in the second cycle. 
4.1.3 Thermal gravimetric analysis 
Thermal behaviour of the samples were investigated by thermal gravimetric analyser 
(TGA) and the results are given in Table 4.3. TGA thermograms of all samples are 
given in Appendix B. According to the TGA results, TPU samples had almost 20% of 
residue. This residue is the inorganic BaSO4 that is blended into TPU to make the 
polymer visible under UV light. 
 
 
 
 
 
 
 
  
32 
 
 
Table 4.3: The results of  TGA 
Code 
Degradation Heat (ºC)   
Onset 
10% Loss of 
Mass 
50% Loss of 
Mass 
 
 
Residue (%) 
TPU 285 296 345 20 
PVP 40 385 392 429 4 
PVP 360 399 402 431 4 
TPU-PVP 40-p 287 299 341 20 
TPU-PVP 40-c 297 306 346 19 
TPU-PVP 360-p 282 297 339 20 
TPU-PVP 360-c 291 302 345 20 
     
4.1.4 Contact angle measurements 
Contact angle measurements were done in order to investigate the hydrophilicity of 
the surfaces. The contact angle of the samples against the  amount of PVP in water 
solution  in coating step is given in the Figure 4.2.  
The contact angle of untreated TPU is about 85
o
. After chemical treatments, the 
contact angle values for TPU-PVP-360 and TPU-PVP-40 are between 69
o
-66
o
 and 
67
o
-45
o
, respectively. Amoung chemical treated samples, most hydrophilic surface 
was obtained for the sample coated with PVP 40 in 20% solution. Similar results are 
reported in the literature. The contact angle of polyurethane measured as 82
o 
by 
Butruk et. al. After coating with PVP 360 and PVP 24 (Mw:24.000 g/mol) the contact 
angles of the samples decreased to 72
o
 and 28
o
, respectively [8]. The results of our 
work is  close to the results of Butruk et. al.  
In the view of plasma treatments, the contact angle values for TPU-PVP-360 and 
TPU-PVP-40  are between 39
o
-21
o
 and 36
o
-17
o
, respectively. Kessler et. al. reported 
that, the addition of PVP K 90 (Mw: 1.400.0000 g/mol) increased the hydrophilicity 
of the surface of polycarbonate membrane. The contact angle decreased from 47
o
 to 
20
o
 after surface treatment by plasma and PVP coating [9]. Khandwekar et. al. 
reported that, the contact angle of polyurethane decreased from 91
o
 to 46
o
 after 
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immobilization of PVP-Iodine into polyurethane [13]. We obtained similar results as 
in the literature. 
According to these results, the most hydrophilic surface can be achieved by first 
plasma modification of TPU and then coating with PVP 40 in 100% solution. 
Generally, samples prepared by plasma method is more hydrophilic then these 
prepared by chemical method. 
 
Figure 4.2: Contact angle values versus PVP amount in water solution graphic 
After waiting 4 days in PBS in order to determine the coating performance of PVP, 
the contact angle of the polymers were investigated. 
4.1.5 Swelling properties of polymers 
The swelling ratios of untreated and coated TPUs are given in Table 4.5. All samples 
have almost the same swelling ratio. In order to determine the coating performance 
of PVP, the aging test was performed. For this, the samples were dipped into PBS 
solution and waited for 4 days. The contact angle changes can be examined in Figure 
4.4. From the results, it is observed that, the contact angles of coated samples by 
plasma were doubled. On the other hand, the contact angles of coated samples by 
chemical method were not dramatically changed. The reason for that might be the 
crosslinking between PVP and TPU because of the cross-linking agent EGDMA used 
in chemical method. 
  
34 
 
Table 4.4: Swelling ratios of the samples 
Code Swelling ratios (%) 
TPU 1,0 
TPU-PVP 40-p 1,1 
TPU-PVP 40-c 0,7 
  TPU-PVP 360-p 1,5 
TPU-PVP 360-c 1,2 
 
 
Figure 4.3: Contact angle change after 4 days in PBS 
4.1.6 Atomic force microscopy  
Atomic force microscopy (AFM) study was done to uncoated TPU, PVP 40 coated  
and synthetic urine solution (SUS) dipped polymers. The roughness for these 
samples are given in Table 4.4. 
The difference in the surface topography can be seen clearly for both plasma and 
chemical treated TPUs. In Figure 4.4 the topology and phase images of the samples 
can be examined. The roughness of untreated TPU was found 23,48 nm. For plasma 
and chemical methods, the roughness were found 134,30 and 761,30, respectively. 
For both chemical and plasma treated samples, the roughness increased significantly. 
This result is expected in according to the literature. In a previous work, the 
roughness of a polyurethane surface were measured to be 9.23 nm. On the other 
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hand, the roughness of PVP-Iodine coated polyurethane was measured as 19,94 nm. 
The coating of PVP-Iodine onto the surface of polyurethane increased the roughness 
[13]. Tunney et. al prepared PVP coated polyurethane. According to their results, the 
surface of  PVP-coated polyurethane was significantly rougher than the surface of 
uncoated polyurethane [25]. It is known that surface roughness excessively increases 
after plasma surface modification on the micrometer and nanometer scale [36]. From 
the phase images, no phase seperations were observed for coated polymers. 
The roughness of SUS rinsed samples were examined in order to compare the 
encrustation. In Figure 4.5, the topography and phase images of  coated and uncoated 
TPUs can be seen.  The roughness of untreated TPU increased about 679% after 
rinsing it into SUS. The roughness of TPU-PVP-40-p and TPU-PVP-40-c increased 
521% and 74%, respectively. According to these results, the crystal deposit 
accumulation is the most on the surface of uncoated TPU. TPU-PVP-40-p is the 
second to have crystal deposits. The least encrustred surface belongs to TPU-PVP-
40-c. This result was confirmed by aging test result.Again, effect of crosslinking 
agent was observed. The crosslinked PVP onto TPU did not come off easily and that 
is why the least encrustred surface belongs to this polymer. From the phase images, 
crystal depositions can be observed. 
The samples were washed with water after removing from SUS.  According to the 
AFM images, the roughness were decreased significantly since the crystals were 
dissolved and the surface roughness decreased by washing the samples. 
Table 4.5: Roughnesses 
 
          Roughnesses of   
Code 
Samples 
(nm) 
SUS Rinsed 
Samples 
(nm) 
After Washing 
SUS Rinsed 
Samples (nm) 
TPU 23,5 228,4 62,5 
TPU-PVP-40-p 134,3 843,5 517,5 
TPU-PVP-40-c 761,3 1326,5 1067,2 
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Figure 4.4: AFM topography images of (a) untreated TPU, (c) TPU-PVP-40-c, (e) 
TPU-PVP-40-p and phase images of samples (b) untreated TPU, (d) TPU-PVP-40-c, 
(f) TPU-PVP-40-p 
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Figure 4.5: AFM images of SUS rinsed samples. Topography images of (a) 
untreated TPU, (c) TPU-PVP-40-c, (e) TPU-PVP-40-p and phase images of  (b) 
untreated TPU, (d) TPU-PVP-40-c, (f) TPU-PVP-40-p 
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4.2 Blending TPU With PVP 
Blend was prepared from TPU and 5% PVP amount in order to determine the effect 
of PVP on hydrophilicity of polymer surface. The contact angle results are given in 
Table 4.6. Both the contact angles of PVP 360 and 40 blended TPUs are almost the 
same with the unmodified TPU. That means blending with PVP does not affect 
surface properties like coating process does.  
Table 4.6 :Comparison of blended and coated and uncoated TPUs’ contact angles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Code Contact Angles (
o
) 
TPU 84 
TPU-PVP 40-p 36 
TPU-PVP 40-c 65 
  TPU-PVP 360-p 39 
TPU-PVP 360-c 66 
TPU-PVP 360-b 87 
TPU-PVP 40-b 85 
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5.  CONCLUSION 
In this work, Catbothane™ PC-3595A-B20 thermoplastic polyurethane (TPU) was 
used as stent material. This commercial TPU is a polycarbonate based aliphatic 
polymer which is highly suitable for biomedical applications. Coating the surface of 
TPU with PVP was achieved by two techniques; plasma and chemical modifications.  
In order to prove the coating, FT-IR studies were performed. The specific peaks for  
–CH groups can be found at the seperated peaks at 2910 and 2850 cm-1. All the 
coated and blended samples gave a peak near to 1660 cm
-1
 which indicating the 
existance of PVP. 
The thermal behaviours of the samples were determined by DSC measurements. For 
TPU-PVP-40-p sample the Tg of both TPU and PVP were determined. Thus, coating 
TPU with PVP was proved. 
According to contact angle results, chemically treated TPU and coating with PVP 
360 and PVP 40 increased the surface hydrophilicity. This lowered the surface 
contact angle from about 84
o
 to 67
o
and 54
o
, respectively. Plasma treatment and then 
coating with PVP 360 and PVP 40 lowered the contact angle from 84
o
 to about 29
o 
and 27
o
. From these results, two main conclusions were pointed: treating with plasma 
gives more hydrophilic surfaces then treating with chemicals and coating with PVP 
40 gives more hydrophilic surfaces than PVP 360. In brief PVP 40 coatings with 
plasma method gives the most hydrophilic surfaces.  
The swelling ratios are almost the same for coated and uncoated TPUs because the 
TPU’s itself swells up only, the PVP coating is so thin to effect swelling properties. 
After 4 days in PBS solution, the contact angles of the samples were measured to 
research the performance of the coating.  The contact angles of plasma treated 
samples were doubled. The contact angles of chemically treated TPUs were almost 
the same. This result can be explained by the effect of the cross-linker in chemical 
treatments.  
According to the AFM results, the uncoated TPU have the lowest roughness value. 
By treating with plasma or chemicals and coating with PVP increased surface 
roughness. The AFM results showed that the roughness increased for TPU, TPU-
  
40 
 
PVP-40-p and TPU-PVP-40-c, respectively. It was observed that, the crosslinking 
effects the performance of the coatings. As the crosslinked PVP coating stays on the 
surface of TPU, the crystal deposits decreases. This was also observed for the PBS 
dipped polymers. Thus, it can be concluded that, plasma treated and coated polymers 
give the most hydrophilic surfaces but their durability against PBS or SUS are poor. 
However, chemically treated and coated polymers are highly durable against PBS 
and SUS. 
The TPU blends with PVP 360 and PVP 40 showed that, blending does not effect the 
surface properties at all. Even though this blending effects the structure of the TPU, 
the surface contact angles are about 85
o
 for both PVP 360 and PVP 40 blended 
TPUs. This result is almost the same with the contact angle of untreated TPU. That 
prooves the importancy and meaning of the surface coating.  
With all these results, it can be concluded that, the stability of the coating is effected 
mostly by crosslinking. Plasma is known to be a more clean method then chemical 
method. But since plasma treatment and dip-coating is not as durable as chemical 
treatment, another plasma method is suggested. Plasma polymerization is also a 
highly clean method to coat the surface. For plasma polymerization, the monomers 
bonds to the surface of substrate with high amount of crosslinks and polymerization 
occurs. Thus, the plasma polymerization is suggested for further experiments. 
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APPENDIX A 
 
Figure A.1: FT-IR spectrum of TPU 
Figure A.2: FT-IR spectrum of PVP 40 
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Figure A.3: FT-IR spectrum of PVP 360 
 
 
Figure A.4: FT-IR spectrum of TPU-PVP-40-p 
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Figure A.5: FT-IR spectrum of TPU-PVP-40-c 
 
 
Figure A.6: FT-IR spectrum of TPU-PVP-360-p 
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Figure A.7: FT-IR spectrum of TPU-PVP-360-c  
 
Figure A.8: FT-IR spectrum of TPU-PVP-360-b 
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Figure A.9: FT-IR spectrum of TPU-PVP-40-b 
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APPENDIX B 
 
 
Figure B.1: TGA spectrum of TPU 
 
Figure B.2: TGA spectrum of PVP 40 
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Figure B.3: TGA spectrum of PVP 360 
 
Figure B.4: TGA spectrum of TPU-PVP-40-p 
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Figure B.5: TGA spectrum of TPU-PVP-40-c 
 
Figure B.6: TGA spectrum of PVP TPU-PVP-360-p 
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Figure B.7: TGA spectrum of TPU-PVP-360-c 
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APPENDIX C 
 
 
Figure C.1: DSC spectrum of TPU 
 
 
Figure C.2: DSC spectrum of PVP 40 
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Figure C.3: DSC spectrum of PVP 360 
 
Figure C.4: DSC spectrum of TPU-PVP-40-p, Tg of TPU 
 
Figure C.5: DSC spectrum of TPU-PVP-40-p, Tg of PVP 
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APPENDIX D 
 
Figure D.1: Contact angle change against PVP concentration for TPU-PVP-40-p 
 
 
Figure D.2: Contact angle change against PVP concentration for TPU-PVP-40-c 
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Figure D.3: Contact angle change against PVP concentration for TPU-PVP-360-p 
 
 
Figure D.4: Contact angle change against PVP concentration for TPU-PVP-360-c 
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Figure D.5 : Contact angle change after dipping into PBS for TPU-PVP-40-p 
 
 
Figure D.6: Contact angle change after dipping into PBS for TPU-PVP-40-c 
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Figure D.7: Contact angle change after dipping into PBS for TPU-PVP-360-p 
 
 
Figure D.8: Contact angle change after dipping into PBS for TPU-PVP-360-c 
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PVP amount in 
solution (%) 
 Contact Angle (
o
)    
PVP 40-p PVP 40-k 
PVP 
360-p 
PVP 
360-k 
Untreated 
TPU 
5 36 65 39 66 81 
10 29 62 33 68 79 
15 30 55 30 69 81 
20 25 45 30 68 78 
30 25 47 26 68 81 
50 27 50 22 66 77 
100 17 52 21 66 76 
 
Table D.1: Contact angle results of all coated samples 
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